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Abstract
Background: Evidence suggests a critical role for the renin-angiotensin system in regulating renal function during
postnatal development. However, the physiological relevance of a highly elevated renin-angiotensin system early
in life is not well understood, nor which angiotensin receptors might be involved. This study was designed to
investigate the roles of angiotensin receptors type 1 (AT1R) and type 2 (AT2R) in regulating glomerular and tubular
function during postnatal development.
Methods: The renal effects of the selective antagonist to AT1R, ZD 7155 and to AT2R, PD 1233319 were evaluated
in two groups of conscious chronically instrumented lambs aged ~ one week (N = 8) and ~ six weeks
(N = 10). Two experiments were carried out in each animal and consisted of the assessment of renal variables
including glomerular and tubular function, for 30 min before (Control) and 60 min after infusion of ZD 7155 and PD
123319, respectively. Statistical significance was determined using parametric testing (Student t-test, analysis of
variance ANOVA) as appropriate.
Results: ZD 7155 infusion was associated with a significant decrease in glomerular filtration rate and filtration
fraction at one but not six weeks; urinary flow rate decreased significantly in older animals, whereas sodium
excretion and free water clearance were not altered. There was an age-dependent effect on potassium handling
along the nephron, potassium excretion decreasing after ZD 7155 infusion in younger but not in older lambs.
PD 123319 had no significant effects on glomerular filtration rate and tubular function in either age group.
Conclusions: These results provide evidence to support an important role for AT1Rs in mediating the renal effects of
angiotensin II during postnatal maturation in conscious developing animals. In contrast to a role for AT2Rs later in life,
there appears to be no role for AT2Rs in influencing the renal effects of Angiotensin II in the postnatal period.
Keywords: Newborn, Kidney, Angiotensin receptor type 1, Angiotensin receptor type 2, Angiotensin II,
Electrolytes, Development
Background
The marked adaptive changes in renal function, includ-
ing renal perfusion pressure, glomerular filtration [4, 35]
and tubular function [5, 7, 10, 22, 24, 25, 44], at the time
of birth may be mediated through complex temporal
and spatial alterations in the level of expression and
functionality of various factors, among which the renin-
angiotensin system (RAS) may play a major role. All
RAS components are highly expressed in numerous tis-
sues and organs including the developing kidney of the
fetus and the newborn and decrease gradually over the
first months in an age-dependent manner (reviewed by
Chen et al. (2004) [15]. Studies in mice, rats, sheep,
swine and humans have shown that the expression and
distribution of the angiotensin receptors (ATRs), type 1
(AT1R) and type 2 (AT2R), is developmentally regulated:
A shift in the expression of ATRs subtypes occurs within
the kidney, including the renal vasculature, from the
AT2Rs, which predominate during fetal life, to AT1Rs
whose expression is low in early gestation and increases
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with age to be the predominant receptor subtype
expressed in the adult [1, 2, 6, 20, 49, 50, 63]. Previous
studies from us in lambs [56] and from others in devel-
oping swine [6], human and simian kidney [63] support
the dogma of altered intra-renal expression of ATRs
genes with maturation.
Although strong evidence suggests the integrity of the
AT1R signalling pathway is a pre-requisite for normal
renal development [15, 28], the physiological effects
mediated by activation of AT1Rs and/or AT2Rs during
ontogeny are not well characterized [58].
Previous studies have shown that during the first six
weeks of postnatal life, the pressor and vasoconstrictor
effects of Angiotensin II (Ang II) are mediated through
exclusive activation of AT1Rs in conscious chronically
instrumented lambs [59]. Neonatal treatment with ACE
inhibitors or AT1Rs antagonists produces irreversible
renal anomalies and alters glomerular and tubular func-
tion in the newborn of several species, including the
human [21, 26, 27, 37, 40, 43]. To date, however, the
physiological relevance of renal AT2Rs during postnatal
maturation is not known.
Therefore, the present study aims to address this gap
in knowledge and investigate the roles of AT2Rs in regu-
lating renal function in the developing kidney. Based on
the anatomical evidence, we hypothesised that, under
physiologic conditions, AT2Rs are more important in
regulating renal function in the newborn, whereas
AT1Rs predominantly regulate glomerular and tubular
function later in life. To this end, we measured the re-
sponses to administration of selective antagonists to
AT1Rs, ZD 7155, and to AT2Rs, PD123319, on various
parameters of glomerular and tubular function in two
groups of conscious chronically instrumented lambs
aged ~ one week, newborns, and later in life, ~six weeks
after birth.
Methods
Animals, maintenance and diet
Experiments were carried out in two age groups of con-
scious, chronically instrumented lambs: newborn lambs,
aged ~ one week (8 ± 1 days; 7.4 ± 0.2 kg body weight;
N = 8), and older animals, aged ~ six weeks (41 ± 1 days;
14.8 ± 0.1 kg body weight; N = 10). The choice of age re-
flects age-dependent major physiological changes that we
have previously documented regarding baseline systemic
and renal haemodynamics [21, 47], circulating levels of
Ang II [39, 42], and the responsiveness of the systemic
vasculature to vasoactive agents [45, 51].
Lambs were obtained from a local source (Woolfitt
Acres, Olds, Alberta) and housed with their mothers in
individual pens in the vivarium of the Health Science
Center except during surgery, training and experiments.
Lambs were allowed to suckle ad libitum. The lactating
ewes were provided with equilibrated diet of proteins,
fat, crude fibers, minerals and vitamins and tap water
at libitum.
All surgical and experimental procedures from this study
were carried out with the approval of the Animal Care
Committee at the University of Calgary, in accordance with
the “Guide to the Care and Use of Experimental Animals”
provided by the Canadian Council on Animal Care.
Surgical procedures
Surgery was performed on lambs using aseptic techniques
as previously described [46, 59]. Following induction of
isoflurane anaesthesia, catheters were inserted into left
and right femoral arteries and veins (Tygon Microbore
Tubing CO., USA) and advanced to the level of abdominal
aorta and inferior vena cava, respectively for later infusion
of drugs and fluids, arterial sampling and pressure mea-
surements during experiments. Through a midline ab-
dominal incision, the bladder was exposed and a catheter
(adapted from a feeding tube, Medi-Craft Ltd., Malton,
Ontario, Canada) was inserted directly across the bladder
wall to be used for measurements of urinary flow rate and
urine sample collection during experiments. A left flank
incision exposed the left kidney and a pre-calibrated ultra-
sonic flow transducer (size 3-6S, Transonic Systems Inc.,
NY, USA) was placed around the renal artery for con-
tinuous measurements of renal blood flow during ex-
periments. The incisions were closed and all catheters
tunneled subcutaneously to exit the animal on the left and
right flanks and secured inside pockets in a lamb body
jacket (Lomir Inc., Montreal, Canada).
After surgery, animals were allowed to recover from the
effects of anaesthesia and surgery inside a Shor-Line inten-
sive care unit for small animals (Schroer Manufacturing
Company, Kansas, USA) with adjustable temperature and
oxygen supply. Lambs were returned to the ewe and
closely monitored until suckling resumed. Antibiotic, Exce-
nel® (Ceftriofur) 2.2 mg/kg, (Pfizer, Kirkland, QC, Canada),
was administered intramuscularly prior to surgery and at
24 h intervals for the following 48 h. For at least four days
of recovery after surgery, the lambs were trained for ap-
proximately one hour each day to rest comfortably in a
supportive sling in the laboratory environment.
Experimental details
On the day of an experiment, each animal was trans-
ported to the laboratory and placed in the supportive
sling. At least 60 min were allowed for the animal to be-
come accustomed to its surroundings, during which a
pre-warmed intravenous (I.V.) infusion of 5 % dextrose
in 0.9 % sodium chloride administered at a rate of
4.17 mL · kg−1 · h−1 through the right femoral venous
catheter was initiated and continued for the duration of
the study in order to assist fluid and electrolyte balance.
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During this time the bladder was allowed to drain. A
priming dose of lithium chloride was injected slowly
(over ten seconds) 30 min before starting the experi-
ments as a bolus injection of 200 μm∙kg−1 for later deter-
mination of proximal tubular Na+ reabsorption, as
previously described [54, 55]. The left femoral venous
and arterial catheters were connected to pressure
transducers (Model P23XL, Statham, West Warwick RI,
USA) for monitoring venous and arterial pressures, re-
spectively. The flow transducer placed around the renal
artery was connected to a flow meter (T101, Transonics
Systems, Ithaca, NY) for measurement of renal blood flow
(RBF). Haemodynamic variables were recorded onto a
polygraph (Model 7, Grass Technologies, Astro-Med Inc.,
West Warwick, RI, USA) and simultaneously digitized
at 200 Hz using the data acquisition and analysis
software package, PolyVIEW™ (AstroMed Inc., Grass
Technologies, Astro-Med Inc., West Warwick, RI, USA).
Two experiments were conducted in random order in
each animal at 48 h intervals and consisted of a control
period for 30 min (Control) followed by I.V. infusion for
60 min of either the angiotensin receptor antagonist, ZD
7155 (experiment one) or PD 123319 (experiment two)
(Tocris Bioscince, Tocris Cookson Inc, Ellisville, MO,
USA). Both drugs were administered as an I.V. infusion of
70 μg · kg−1 · h−1 following an I.V. bolus of 100 μg · kg−1
using an infusion pump (Microinfusion pump MI 60-1B,
World Precision Instruments, Sarasota, Fl, USA).
These doses were carefully selected from previous
dose–response experiments [14].
Urine was collected continuously and sampled at
30 min intervals. At the end of each collection period,
urinary flow rate (V) was recorded and urine samples
stored at −70 °C for later measurement of urinary elec-
trolytes (Na+, K+, Li+, Cl−), urinary creatinine concentra-
tion and urinary osmolality (UOsm). At the midpoint of
each 30 min urinary collection, blood samples (3.5 mL)
were removed from the femoral arterial catheter. Whole
blood (0.5 mL) was used for immediate measurement of
haematocrit (Hct) using a microhaematocrit centrifuge
(Clay Adams, Parsippany, NJ, USA). The remainder was
placed into a chilled heparinised tube and immediately
centrifuged; the supernatant was removed and stored at
−70 °C for later measurement of the plasma concentrations
of electrolytes (Na+, K+, Cl−), plasma creatinine concentra-
tion and plasma osmolality. The volume of blood drawn
was replaced with equal volumes of 5 % dextrose in 0.9 %
NaCl to minimise the haemodynamic effects of sampling.
At the end of the experiments, lambs were euthanised
with a lethal dose of barbiturate. The placement of the
catheters was verified and the zero offset of the flow
transducer was measured. Both kidneys were removed,
examined grossly, and weighed to normalise measure-
ments between the two age groups.
Analytical procedures
Urinary and plasma electrolytes (Na+, K+, Li+, Cl−), were
measured on thawed samples by ion chromatography
(IC 680, Methrom AG, Herisau, Switzerland). Urinary
and plasma osmolalities were measured using a micro-
osmometer (2430 Multi-OSMETTE™, Precision Systems
Inc., Natic, MA, USA). Creatinine concentrations in
urine and plasma were measured using a commercially
available creatinine assay kit (QuantiChrom Creatinine
assay kit, BioAssays Systems, Hayward, CA). Electrolyte
concentrations in urine and plasma were used to calcu-
late excretion rates, clearances, and reabsorptions. Cre-
atinine measurements in urine and plasma were used to
estimate glomerular filtration rate. Osmolality measure-
ments in urine and plasma were used to calculate osmo-
lar clearances and tubular water handling.
Data handling and analyses
Renal plasma flow (RPF) was calculated using the for-
mula: RPF (mL/min) = [1 - (RBF x Hct)]. GFR was esti-
mated as creatinine clearance: GFR = (UCr x V)/PCr.
Filtration fraction (FF) was determined as GFR/RPF.
Clearances of electrolytes (X) were calculated as follows:
CX = (UX x V)/PX, where U and P refers to urinary and
plasma concentrations of the electrolyte X and V is urin-
ary flow rate. Fractional reabsorption (FR) of electrolytes
was calculated from the ratio of electrolyte clearance to
GFR: FRx (%) = [1- (CX/GFR)] x100. Proximal tubular
Na+ reabsorption was assumed equal to fractional Li+
clearance (CLi/GFR). Free water clearance was calcu-
lated as the difference between urinary flow rate (V) and
osmolar clearance. The ratio of urinary Na+ concentration
to urinary K+ (UNa/UK) as well as the transtubular K+
gradient (TTKG) were also calculated (TTKG= (UK/PK)/
(UOsm/POsm), where UOsm/POsm is the ratio of UOsm
to POsm and UK and PK are concentration of K+ in urine
and respectively plasma).
Renal haemodynamic variables and parameters of
renal function were normalized per gram kidney weight
to allow comparisons between the two different age
groups since kidney weights were different at one and
six weeks (Table 1).
Statistical analyses
Data were tested for normal distribution before statis-
tical procedures were applied. Student’s unpaired t-test
was used to compare baseline measurements between
the two groups. Two-way analysis of variance (ANOVA)
procedures for repeated measures over time with
factors age and treatment followed by Holm Sidak
multiple comparisons were appropriate were used to
compare the effects of the treatments between the
groups. The Bonferroni correction was used to adjust
for multiple comparisons. Significance was accepted
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at the 95 % confidence interval. Data analysis was
carried out using IBM SPSS statistical software (IBM
SPSS Statistics for Windows, version 20.0, IBM




The demographic characteristics and baseline variables
of the two groups of lambs are presented in Table 1.
Resting renal haemodynamics variables were signifi-
cantly different between the groups; RVR was lower,
whereas RBF was at higher at six weeks than at one
week. There were no significant differences in baseline
GFR when normalized per kidney weight between the
two age groups. RPF and UOsm were significantly lower
whereas FF was higher at one week as compared to six
weeks. UKV and UClV were similar in both age groups,
while CK and CNa were higher at six weeks.
Renal effects of the AT1R antagonist, ZD 7155
Infusion of ZD 7155 significantly altered systemic and
renal haemodynamics variables in one and six week old
lambs. As shown in Additional file 1: Table S1, arterial
pressure fell by approximately 10 % within 10 min of in-
fusion in both age groups of lambs, from 73 ± 6 mmHg
to 63 ± 6 mmHg in one week old lambs and from 77 ± 5
to 69 ± 5 mmHg in six weeks old lambs (p < 0.001).
Within 10 min of ZD 7155 infusion, RVR decreased in
both age groups, whereas RBF increased from 4.1 ± 1.8
to 5.0 ± 2.1 ml · min−1 · g−1 (p < 0.001) in older lambs and
did not change in younger ones.
After ZD 7155 infusion, RPF increased in six but not
in one week old lambs, from 5.7 ± 2.2 to 6.5 ± 2.5 ml ·
min−1 · g−1 (p = 0.018). There was an age-dependent effect
of ZD 7155 on GFR (F = 3.911, p = 0.031), which decreased
in one week old lambs from 0.43 ± 0.13 ml · min−1 · g−1 to
0.24 ± 0.18 ml · min−1 · g−1 (p = 0.010). ZD 7155 did not
significantly alter GFR in older lambs, although GFR
tended to decline in this group as well, albeit to a lesser
extent (from 0.43 ± 0.19 ml · min−1 · g−1 to 0.37 ±
0.16 ml · min−1 · g−1) (Fig. 1). Following the changes in
RPF and GFR, ZD 7155 elicited age-dependent effects
on FF (F = 5.889, p = 0.009). FF decreased from 48 ± 25
to 30 ± 26 % (p = 0.002) at one week and from 20 ± 10
to 12 ± 8 % at six weeks (p = 0.145) (Fig. 1).
Whereas UNaV was not influenced by the ZD 7155 treat-
ment in either age group (Fig. 2), effects on K+ excretion
were age-dependent (F = 8.391, p = 0.001): ZD 7155 signifi-
cantly decreased UKV in younger animals, from 0.62 ± 0.32
to 0.28 ± 0.22 μmol · min−1 · g−1 but not in older ones
(Fig. 2). This was accompanied by a decrease in TTKG by
almost 30 % in younger lambs (p < 0.001) (Table 2). There
was a trend towards an increase in the UNa/UK ratio after
ZD 7155 infusion at one week but not six weeks (p = 0.08).
There were no significant effects of the AT1R antagonist
on Na+ and K+ reabsorption rates or CK in both groups of
lambs (Table 2). CNa was altered by the infusion of ZD
7155 in an age-dependent manner: CNa increased in six
but not one week old lambs (F = 28.577, p < 0.001).
Table 1 Baseline demographic, haemodynamics, plasma and
renal variables in conscious lambs
One week Six weeks
Animal characteristics
Sample size, n 8 10
Sex 3♀/5♂ 7♀/3♂
Age, days 8 (1) 41 (1)*
Kidney weight, g 62.9 (15.1) 80.6 (7.7)*
Baseline haemodynamics
MAP, mmHg 72 (7) 77 (5)*
RBF, mL · g−1 · min−1 1.7 (0.6) 4.0 (1.6)*
RVR, mmHg · g−1 · min−1 44.7 (16.6) 19.1 (7.2)*
Baseline renal variables
RPF, mL · g−1 · min−1 1.07 (0.33) 5.60 (2.01)*
GFR, mL · g−1 · min−1 0.39 (0.16) 0.37 (0.20)
FF, % 39.2 (22.8) 18.24 (11.6)*
V, μL · g−1 · min−1 4.6 (1.5) 4.9 (3.4)
CH2O, μL · g−1 · min−1 −3.7 (2.8) −8.3 (5.2)*
POsm, mOsm/kgH2O 303 (9) 301 (8)
UOsm, mOsm/kgH2O 627 (201) 835 (289)*
COsm, μL · g−1 · min−1 7.9 (3.4) 10.6 (3.5)*
Plasma concentrations
PNa, mmol · L−1 143.2 (5.5) 144.8 (9.3)
PK, mmol · L−1 3.5 (0.3) 3.7 (0.4)
PCl, mmol · L−1 65.4 (2.4) 64.7 (3.5)
Urinary excretion rates
UNaV, μmol · g−1 · min−1 0.05 (0.06) 0.05 (0.03)
UKV, μmol · g−1 · min−1 0.51 (0.26) 0.84 (0.23)*
UClV, μmol · g−1 · min−1 0.13 (0.12) 0.16 (0.11)
UNa/UK 0.07 (0.05) 0.08 (0.05)
TTKG 17.8 (6.9) 16.7 (3.1)
Renal clearances
CNa, μL · g−1 · min−1 0.2 (0.1) 1.1 (0.6)*
CCl, μL · g−1 · min−1 2.0 (1.9) 2.4 (1.4)
CK, mL−1 · min−1 0.15 (0.1) 0.63 (0.3)*
Values are presented as mean (SD). *p < 0.05 six weeks compared with
one week
MAP mean arterial pressure, RBF renal blood flow, RVR renal vascular resistance,
GFR glomerular filtration rate, RPF renal plasma flow, FF filtration fraction,
V urinary flow rate, PX plasma concentration of electrolyte X, UXV urinary
excretion rate of electrolyte X, CX clearance of electrolyte X, UNa/UK urine Na+ to
K+ ratio, TTKG transtubular K+ gradient, UOsm urinary osmolality, COsm clearance
of osmoles, CH2O free water clearance
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V fell by ~ 50 % within 60 min of ZD 7155 infusion in
older lambs (p = 0.006). Similar, there was a trend for V
to decrease in younger animals; however, this did not
reach statistical significance (p = 0.058) (Fig. 2).
There were also age-dependent effects of ZD 7155
treatment on UOsm (F = 27.721, p < 0.001) and COsm
(F = 7.267, p = 0.017). UOsm increased in six but not one
week old lambs after 60 min of AT1R antagonist infu-
sion (p = 0.004) (Fig. 2), whereas COsm decreased in one
week old lambs (p < 0.001) (Table 2). There were no ef-
fects of ZD 7155 on CH2O or the UOsm/POsm ratio in
either age group.
Fig. 1 Effects of ATR antagonists, ZD 7155 and PD 123319, on glomerular function in conscious lambs. Effects of ATR antagonists, ZD 7155 and PD
123319 on glomerular filtration rate (GFR; panel a and b), and filtration fraction (FF; panel c and d) in conscious lambs aged ~ one week (open bars)
and ~ six weeks (closed bars) measured before (Control, c) and for 60 min after intravenous infusion of ZD 7155 (panels a and c, striped line bars) or PD
123319 (panels b and d, gray shaded bars). *p < 0.001 compared to C; †p < 0.05 compared to one week
Fig. 2 Effects of AT1R antagonist, ZD 7155 on tubular function in conscious lambs. Effects of AT1R antagonist, ZD 7155, on urinary Na+ excretion
rate (UNaV, panel a), urinary K+ excretion rate (UKV, panel c), urinary flow rate (V, panel b), and urine osmolality (UOsm, panel d) in conscious
lambs aged ~ one week (open bars) and ~ six week (closed, striped line bars) measured before (Control, c) and for 60 min after intravenous infusion
of ZD 7155. *p < 0.001 compared to c; †p < 0.05 compared to one week
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Renal effects of PD 123319
The AT2R antagonist, PD 123319 had no significant ef-
fects on systemic and renal haemodynamics in either
group of animals (Additional file 1: Table S1). There
were also no changes in RPF, GFR or FF after infusion of
PD 123319 (Fig. 1) in either age group. Also, no changes
were observed in urine production (Fig. 3) and electro-
lyte excretion rates of Na+, K+, (Fig. 3) and Cl− (Table 3)
after PD 123319 at one and six weeks. PD 123319 infu-
sion did not alter reabsorption rates and clearances of
electrolytes, urine osmolality nor osmolar clearance
(Table 3).
Administration of ATRs antagonists, ZD 7155 and PD
123319, had no significant effects on plasma Na+, K+ and
Cl− concentration, nor did it influence plasma osmolality
in either of the age groups (Additional file 2: Table S2).
Discussion
The present study, exploring the potential roles of Ang
II receptors type 1, AT1Rs and type 2, AT2Rs in
Table 2 Tubular effects of the AT1R antagonist ZD 7155 in conscious lambs
Variable One week Six weeks
Control 30 min 60 min Control 30 min 60 min
CNa (μL · g−1 ·min−1) 0.24 ± 0.05 0.18 ± 0.08 0.21 ± 0.16 0.90 ± 0.52** 0.94 ± 0.42** 0.62 ± 0.29**,*
FRNa % 99.93 ± 0.03 99.90 ± 0.08 99.73 ± 0.60 99.90 ± 0.12 99.84 ± 0.23 99.89 ± 0.12
PRNa % 78.3 ± 8.8 81.8 ± 9.1 84.1 ± 10.8 70.4 ± 19.1** 69.4 ± 21.1** 70.1 ± 15.6**
DRNa % 21.7 ± 8.8 18.1 ± 9.1 15.6 ± 10.6 29.5 ± 19.1** 30.6 ± 21.6** 29.8 ± 15.6**
CK (mL · g−1 ·min−1) 0.18 ± 0.10 0.09 ± 0.08 0.09 ± 0.07 0.64 ± 0.34** 0.45 ± 0.16** 0.39 ± 0.16**
FRK % 59.2 ± 17.1 66.0 ± 16.3 64.3 ± 23.7 56.7 ± 18.9 53.5 ± 14.3 57.0 ± 26.0
UNa/UK 0.08 ± 0.03 0.15 ± 0.13 0.12 ± 0.10 0.07 ± 0.04 0.10 ± 0.09 0.10 ± 0.10
TTKG 21 ± 7 17 ± 4* 16 ± 2* 17 ± 3 16 ± 3 16 ± 2**
CCl (μL · g−1 ·min−1) 2.0 ± 1.0 1.2 ± 0.9 0.9 ± 0.5* 2.2 ± 1.0 2.5 ± 1.7 2.6 ± 1.5
FRCl % 99.51 ± 0.24 99.46 ± 0.33 99.31 ± 0.92* 99.29 ± 0.39 99.62 ± 1.82 99.15 ± 0.49**
COsm (μL · g−1 ·min−1) 8.9 ± 1.3 4.6 ± 3.3* 4.2 ± 1.4* 10.1 ± 3.1 8.5 ± 3.3** 8.2 ± 1.9**
UOsm/POsm 1.9 ± 0.5 2.2 ± 0.8 2.2 ± 0.6 2.8 ± 1.2 2.7 ± 1.1 3.1 ± 1.2
CH2O (μL · g−1 ·min−1) −5.1 ± 1.4 −3.1 ± 2.9 −2.3 ± 1.2 −6.9 ± 2.8 −5.7 ± 2.8 −5.6 ± 2.4**
Data are mean ± SD. *p < 0.05 compared to C; **p < 0.05 compared to one week old lambs
CX clearance of electrolyte X, FRX fractional reabsorption of electrolyte X, PRX proximal reabsorption of electrolyte X, DRX distal reabsorption of electrolyte X,
UNa/UK urine Na+ to K+ ratio, TTKG transtubular K+ gradient, UOsm urinary osmolality, COsm clearance of osmoles, CH2O free water clearance
Fig. 3 Effects of AT2R antagonist PD 123319 on tubular function in conscious lambs. Effects of AT2R antagonist, PD 123319 on urinary Na+ excretion
rate (UNaV, panel a), urinary K+ excretion rate (UKV, panel c), urinary flow rate (V, panel b), and urine osmolality (UOsm, panel d) in conscious lambs
aged ~ one week (open bars) and ~ six week (closed, gray shaded bars) measured before (Control, c) and for 60 min after intravenous infusion of ZD
7155. *p < 0.001 compared to c; †p < 0.05 compared to one week
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regulating renal function during postnatal maturation,
provides new information on the renal effects of ATRs
during the newborn period as follows: i) glomerular
ultrafiltration is regulated by Ang II through activation
of AT1Rs in an age-dependent manner; ii) production of
urine is modulated by activation of AT1Rs predomin-
antly later in life; iii) AT1Rs mediate the effects of Ang
II of K+ handling along the nephron in an age-
dependent manner; iv) AT2Rs alone do not appear to
mediate any of the glomerular and tubular effects of
Ang II in the newborn period. Therefore, our current
findings provide new evidence that, early in life, in con-
scious animals, Ang II regulates both, glomerular and
tubular function through predominant activation of
AT1Rs but not AT2Rs.
To our knowledge, no previous studies have explored
the roles of ATRs in regulating kidney function in new-
borns in the conscious, undisturbed state. To date, the
evidence is limited to the roles of AT1Rs and comes
from studies in anaesthetised newborns animals. For in-
stance, in anaesthetised newborn rabbits, the AT1R an-
tagonist, losartan, elicits dose-dependent systemic and
glomerular responses [40]. In neonatal rats, chronic sub-
cutaneous administration of DuP 753 decreased arterial
pressure but left GFR unchanged [16]. Intra-renal infu-
sion of the AT1R antagonist A-81988, increased RBF in
three weeks old piglets, while the effects on glomerular
function were similar in young and adult anaesthetised
pigs [52]. This is in contrast with transient effect of the
selective AT1R antagonist, ZD 7155 on GFR only in
newborns lambs observed in the current experiments in
conscious lambs. The differences in responses to AT1R
inhibition may be a consequence of selectivity, dose and
mode of administration of the drugs (systemic vs. in-
trarenal), or related to variability in terms of age, renal
maturation (level of expression and localization of the
receptors within kidney regions in different species), as
well as the experimental setting (anaesthetised vs. con-
scious). Anaesthesia has been shown to activate the RAS
and it is conceivable that, in the anaesthetised animals,
the RAS is up-regulated to levels much higher than that
of conscious newborn animals.
Based on the distinct pattern of ATRs distribution in the
developing kidney in several species, including porcine,
ovine and primate kidney [6, 29, 30, 41, 49, 56, 57, 61, 63],
we hypothesised that immediately after birth activation
of AT2Rs may contribute to the adaptation of glomeru-
lar function in the immediate newborn period. This
was not the case. Our study shows that endogenous
Ang II effects on glomerular function are mediated
entirely through activation of AT1Rs, likely through a
predominant effect on efferent arterioles, with no ap-
parent role for AT2Rs. Nonetheless, the contribution of
AT2R in regulating vasomotor activity of the intrarenal
vasculature cannot be ruled out at this time and re-
mains to be elucidated.
The intriguing observation that the decline of GFR
after ZD 7155 was not sustained in newborn lambs des-
pite the continued inhibition of AT1Rs, also lends sup-
port to the concept of redundant mechanisms that are,
most likely, already in place at birth. Thus, the newborn
kidney is probably able to mobilise additional vasoactive
factors to maintain glomerular filtration. For example,
AT1R inhibition may have revealed the role of other
Table 3 Tubular effects of the AT2R antagonist PD 123319 in conscious lambs
Variable One week Six weeks
Control 30 min 60 min Control 30 min 60 min
CNa (μL · g−1 ·min−1) 0.14 ± 0.08 0.23 ± 0.18 0.36 ± 0.44 1.2 ± 0.6** 1.0 ± 0.5** 1.4 ± 1.2**
FRNa % 99.89 ± 0.13 99.85 ± 0.22 99.75 ± 0.30 99.88 ± 0.09 99.86 ± 0.13 99.86 ± 0.14
PRNa % 78.8 ± 11.2 80.1 ± 8.8 77.9 ± 8.3 67.0 ± 20.3** 67.4 ± 20.2** 72.7 ± 21.0**
DRNa % 21.1 ± 11.1 19.8 ± 8.7 21.9 ± 8.1 35.9 ± 19.0** 35.5 ± 18.8** 29.5 ± 20.8**
CK (mL · g−1 ·min−1) 0.11 ± 0.10 0.12 ± 0.06 0.09 ± 0.03 0.62 ± 0.28** 0.47 ± 0.12** 0.42 ± 0.18**
FRK % 66.7 ± 16.2 66.7 ± 15.9 62.1 ± 16.2 52.8 ± 27.6 47.3 ± 24.3 68.1 ± 16.7
UNa/UK 0.07 ± 0.05 0.09 ± 0.06 0.14 ± 0.14 0.09 ± 0.05 0.11 ± 0.09 0.10 ± 0.09
TTKG 15 ± 5 15 ± 5 13 ± 5 17 ± 3 14 ± 2* 13 ± 4*
CCl (μL · g−1 ·min−1) 2.1 ± 2.1 2.5 ± 2.0 2.1 ± 2.0 2.7 ± 1.8 2.4 ± 1.6 2.8 ± 1.5
FRCl % 99.42 ± 0.39 99.45 ± 0.42 99.30 ± 0.66 99.97 ± 0.02 99.97 ± 0.02 99.97 ± 0.02
COsm (μL · g−1 ·min−1) 7.2 ± 3.9 8.1 ± 4.2 7.4 ± 2.8 10.9 ± 3.7 11.4 ± 3.2 11.1 ± 5.4
UOsm/POsm 1.7 ± 0.5 1.7 ± 0.5 2.0 ± 0.7 2.4 ± 0.7 2.8 ± 0.9 2.1 ± 0.7
CH2O (mL · g
−1 · min−1) −3.2 ± 2.7 −3.2 ± 2.4 −2.6 ± 2.1 −7.5 ± 3.3** −7.1 ± 1.9** −5.7 ± 3.7
Data are mean ± SD. *p < 0.05 compared to C; **p < 0.05 six weeks compared to one week
V urinary flow rate, CX clearance of electrolyte X, FRX fractional reabsorption of electrolyte X, PRX proximal reabsorption of electrolyte X, DRX distal reabsorption of
electrolyte X, UNa/UK urine Na+ to K+ ratio, TTKG transtubular K+ gradient, UOsm urinary osmolality, COsm clearance of osmoles, CH2O free water clearance
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vasoactive factors, such as prostaglandins, bradykinin, or
nitric oxide. Previously, we have reported that the renal
haemodynamic effects of nitric oxide are regulated by
Ang II through activation of both ATRs [57, 60] in an
age-dependent manner, with AT2Rs being a more im-
portant regulator of renal haemodynamics in the new-
born and AT1Rs more predominant later in life [57].
Also, pre-treatment with the cyclooxygenase inhibitor,
indomethacin, augments the pressor response to Ang II
and modulates the vasomotor effect of Ang II in response
to infusion of the nitric oxide inhibitor, L-NAME, thus re-
moving endogenously produced nitric oxide [23]. Taken
together, these findings may suggest that AT2Rs may not
need to be recruited to assist in regulating glomerular
function in the face of the numerous vasodilators already
present.
In adulthood, the effects of Ang II in regulating so-
dium transport within the kidney, ranging from natri-
uresis to antinatriuresis are mediated through multiple
receptors, including AT1Rs and AT2Rs. Much less is
known about Ang II contribution to Na+ handling in
newborn mammals [29, 32, 53]. For example, in adult
animals, in which the RAS is activated by dietary salt re-
striction, treatment with ACE inhibitors elicits a robust
increase in water and electrolyte excretion [12, 36].
Therefore, we anticipated that, in newborn lambs, in
which the RAS is also activated [9, 34], there would be a
significant increase in water and electrolyte excretion
after ATRs inhibition. We also predicted that AT2Rs,
which are the predominant type of ATRs expressed
within the kidney after birth, may play a predominant
role in water and electrolyte handling in the newborn.
This was not the case. Effects of Ang II on renal hand-
ling of water and electrolytes appeared rather to be me-
diated predominantly through activation of AT1Rs in an
age-dependent manner, whereas AT2Rs do not appear to
regulate water and salt handling along the nephron in
developing animals.
The decrease in K+ excretion in young animals re-
ported in the present study may be due to inhibition of
aldosterone secretion through a feedback mechanism at
the adrenal gland level, or by inhibition of possible direct
regulatory mechanisms of Ang II on K+ channels along
the collecting duct. The decrease in the flow of tubular
fluid in this age group may have contributed to a fall in
K+ secretion and, therefore, a reduction in K+ excretion
rate. Absence of significant changes in the UNa/UK ratio
may suggest that aldosterone levels may not have been
altered after ATRs inhibition. Further studies are needed
to explore more in depth the effects of ATRs inhibition
on aldosterone activity in newborn.
Our findings are in keeping with observations of the
renal effects of the AT1R antagonist losartan in adult,
salt-depleted animals, in which the RAS is also activated,
similar to newborn lambs in the present experiments
[3, 8, 17, 19, 62]. For instance, in sodium-depleted
anaesthetised adult rats, AT1R antagonists decreased
GFR, urine and electrolytes excretion [16, 33], whereas in
sodium-depleted conscious and anaesthetised adult dogs,
AT1R antagonists increased GFR and elicited a significant
increase in urine volume and urinary sodium excretion
rate [8, 18, 31]. However, in this species, AT2R inhibition
antagonized the vasoconstrictor effects of exogenous Ang
II and induced an increase in urine flow and free water
formation, suggesting a functional role for AT2Rs in water
handling by the adult kidney [18, 31]. Other studies in
adult animals have shown a role for AT2R in mediating
vasodilation, natriuresis and diuresis [11, 38], albeit these
effects were revealed in anesthetised animals, in condi-
tions of RAS activation and AT1Rs inhibition. As such, an
age-dependent functional role for AT2R in renal homeo-
stasis awaits confirmation.
Strengths and limitations
There are several limitations to our study: i) Due to the
technical limitations of surgery and postoperative recov-
ery, the effects of ATRs activation immediately after birth,
especially within the first few days after birth could not be
evaluated; ii) The sample size in this study was predeter-
mined in order to identify significant changes in arterial
pressure [13, 59]. Heterogeneity in study designs and lack
of power calculations in most of the previous reports that
investigated the effects of ATRs in newborns, offered lim-
ited information for sample size calculation in our study;
iii) For some of the physiologic variables studied, a trend
in changes was observed that did not reach statistical sig-
nificance. This may be altered if the group sizes were con-
siderably larger although our previous evaluations of renal
function in these two age groups have revealed significant
differences with similar sample sizes [39, 48]; iv) We were
not able to describe the continuum of changes in ATRs
functions from one to six weeks after birth, thus we could
not determine the postnatal age at which the changes in
the activity of ATRs occur. On the other hand, as opposed
to the previous studies in fetal animals, which provide
only a snapshot of the ATRs function at one gestational
age, our study evaluated renal effects of ATRs antagonists
at two different stages of postnatal development, thus pro-
viding an insight into the physiological changes of renal
function that occur with the process of maturation and
transition to adulthood. Furthermore, our study was
conducted in conscious animals, trained to the laboratory
environment, and, therefore, the findings represent
physiological conditions.
Conclusions
In summary, the present observations provide evidence
for a more important role for Ang II through AT1Rs in
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governing renal function during the critical period of
postnatal development and adaptation to extra-uterine
life. AT1Rs are the predominant effectors of Ang II me-
diated renal effects throughout postnatal maturation,
whereas the physiological functions of AT2R in modulat-
ing the kidney have not been elucidated. Additional
studies are warranted to explore potential roles of the
AT2Rs in modulating AT1R-mediated renal responses
during ontogeny.
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